A high-profile study that purported to provide the first reassurances ACE inhibitors and ARBs could be safely used in the setting of COVID-19 continues to be cited long after it was retracted over ...
The routine use of protamine for heparin reversal during TAVI improves and hastens hemostasis, data from the randomized ACE-PROTAVI trial confirm. The results, published online this week in JAMA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback